Somatic Mutaome Profile in Human Cancer Tissues.
- Author:
Nayoung KIM
1
;
Yourae HONG
;
Doyoung KWON
;
Sukjoon YOON
Author Information
- Publication Type:Original Article
- Keywords: human tissue samples; metastasis; mutation frequency; TCGA
- MeSH: Antineoplastic Agents; Exome; Genome; Humans*; Lung Neoplasms; Mutation Rate; Neoplasm Metastasis
- From:Genomics & Informatics 2013;11(4):239-244
- CountryRepublic of Korea
- Language:English
- Abstract: Somatic mutation is a major cause of cancer progression and varied responses of tumors against anticancer agents. Thus, we must obtain and characterize genome-wide mutational profiles in individual cancer subtypes. The Cancer Genome Atlas database includes large amounts of sequencing and omics data generated from diverse human cancer tissues. In the present study, we integrated and analyzed the exome sequencing data from ~3,000 tissue samples and summarized the major mutant genes in each of the diverse cancer subtypes and stages. Mutations were observed in most human genes (~23,000 genes) with low frequency from an analysis of 11 major cancer subtypes. The majority of tissue samples harbored 20-80 different mutant genes, on average. Lung cancer samples showed a greater number of mutations in diverse genes than other cancer subtypes. Only a few genes were mutated with over 5% frequency in tissue samples. Interestingly, mutation frequency was generally similar between non-metastatic and metastastic samples in most cancer subtypes. Among the 12 major mutations, the TP53, USH2A, TTN, and MUC16 genes were found to be frequent in most cancer types, while BRAF, FRG1B, PBRM1, and VHL showed lineage-specific mutation patterns. The present study provides a useful resource to understand the broad spectrum of mutation frequencies in various cancer types.
